What is the address of DUQUESNE LEGAT KINESITHERAPIE?

The registered office of DUQUESNE LEGAT KINESITHERAPIE is located at Rue Saint Roch(VBR) 17, 7120 Estinnes.

Is DUQUESNE LEGAT KINESITHERAPIE still active?

Yes. According to the CBE (21 September 2026) DUQUESNE LEGAT KINESITHERAPIE is active, legal situation “Normale toestand”, started on 4 October 2018.

Is DUQUESNE LEGAT KINESITHERAPIE registered on Peppol?

Yes, DUQUESNE LEGAT KINESITHERAPIE is registered on the Peppol network with ID 0208:0707750602.

What is the enterprise number of DUQUESNE LEGAT KINESITHERAPIE?

The enterprise number of DUQUESNE LEGAT KINESITHERAPIE is BE0707750602.

When was DUQUESNE LEGAT KINESITHERAPIE founded?

DUQUESNE LEGAT KINESITHERAPIE was founded on 4 October 2018.

Who are the directors of DUQUESNE LEGAT KINESITHERAPIE?

According to the 2025 annual accounts, the directors of DUQUESNE LEGAT KINESITHERAPIE are: Jeanne Duquesne, Axel Legat.

Is DUQUESNE LEGAT KINESITHERAPIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 4 October 2018; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did DUQUESNE LEGAT KINESITHERAPIE make in 2025?

DUQUESNE LEGAT KINESITHERAPIE posted a profit after taxes of € 39,687 in financial year 2025.

What is the revenue of DUQUESNE LEGAT KINESITHERAPIE?

As a small company, DUQUESNE LEGAT KINESITHERAPIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 84,929.

DUQUESNE LEGAT KINESITHERAPIE (Private Limited)

Dossier DUQUESNE LEGAT KINESITHERAPIE, printed on 21 September 2026 from databakkes.be/en/0707750602/duquesne-legat-kinesitherapie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DUQUESNE LEGAT KINESITHERAPIE from Estinnes, company number BE0707750602, closed financial year 2025 with a result of € 39,687 after tax. For that financial year DUQUESNE LEGAT KINESITHERAPIE recorded a gross margin of € 84,929 and equity of € 75,747. Compared with financial year 2024, the result moved from € 37,231 to € 39,687. Profitable, and profit is growing. The buffer shrank hard: equity is 53 % below last year. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 29, 2026.

What it is worth Shrank hard

€ 75,747

▼ 53% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 39,687

▲ 7% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 65,142

▼ 31% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 123,483 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 6,892

▼ 62% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 30,517

▼ 41% vs 2024

€ 9,535 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 2,368

▲ 32% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 12,377

▲ 103% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 124,653 Gross margin 2022: € 124,653 First fiscal year in the series	€ 95,764 Gross margin 2023: € 95,764 ▼ 23% vs 2022 (€ 124,653) Unfavourable step	€ 82,382 Gross margin 2024: € 82,382 ▼ 14% vs 2023 (€ 95,764) Unfavourable step	€ 84,929 Gross margin 2025: € 84,929 ▲ 3% vs 2024 (€ 82,382) Favourable step	▲ 3%
Profit after taxes	€ 69,937 Profit after taxes 2022: € 69,937 First fiscal year in the series	€ 54,882 Profit after taxes 2023: € 54,882 ▼ 22% vs 2022 (€ 69,937) Unfavourable step	€ 37,231 Profit after taxes 2024: € 37,231 ▼ 32% vs 2023 (€ 54,882) Unfavourable step	€ 39,687 Profit after taxes 2025: € 39,687 ▲ 7% vs 2024 (€ 37,231) Favourable step	▲ 7%
Equity	€ 165,948 Equity 2022: € 165,948 First fiscal year in the series	€ 162,991 Equity 2023: € 162,991 ▼ 2% vs 2022 (€ 165,948) Unfavourable step	€ 159,543 Equity 2024: € 159,543 ▼ 2% vs 2023 (€ 162,991) Unfavourable step	€ 75,747 Equity 2025: € 75,747 ▼ 53% vs 2024 (€ 159,543) Unfavourable step	▼ 53%
Total debts	€ 91,750 Total debts 2022: € 91,750 First fiscal year in the series	€ 141,063 Total debts 2023: € 141,063 ▲ 54% vs 2022 (€ 91,750) Unfavourable step	€ 59,625 Total debts 2024: € 59,625 ▼ 58% vs 2023 (€ 141,063) Favourable step	€ 120,721 Total debts 2025: € 120,721 ▲ 102% vs 2024 (€ 59,625) Unfavourable step	▲ 102%
Cash	€ 111,445 Cash 2022: € 111,445 First fiscal year in the series	€ 153,708 Cash 2023: € 153,708 ▲ 38% vs 2022 (€ 111,445) Favourable step	€ 94,512 Cash 2024: € 94,512 ▼ 39% vs 2023 (€ 153,708) Unfavourable step	€ 65,142 Cash 2025: € 65,142 ▼ 31% vs 2024 (€ 94,512) Unfavourable step	▼ 31%
Retained profit	€ 159,748 Retained profit 2022: € 159,748 First fiscal year in the series	€ 156,791 Retained profit 2023: € 156,791 ▼ 2% vs 2022 (€ 159,748) Unfavourable step	€ 153,343 Retained profit 2024: € 153,343 ▼ 2% vs 2023 (€ 156,791) Unfavourable step	€ 69,547 Retained profit 2025: € 69,547 ▼ 55% vs 2024 (€ 153,343) Unfavourable step	▼ 55%
Dividend	€ 1,364 Dividend 2022: € 1,364 First fiscal year in the series	€ 57,838 Dividend 2023: € 57,838 ▲ € 56,474 vs 2022 (€ 1,364) Unchanged	€ 40,679 Dividend 2024: € 40,679 ▼ 30% vs 2023 (€ 57,838) Unchanged	€ 123,483 Dividend 2025: € 123,483 ▲ 204% vs 2024 (€ 40,679) Unchanged	▲ 204%
Bank debt	€ 81,142 Bank debt 2022: € 81,142 First fiscal year in the series	€ 74,676 Bank debt 2023: € 74,676 ▼ 8% vs 2022 (€ 81,142) Favourable step	€ 51,724 Bank debt 2024: € 51,724 ▼ 31% vs 2023 (€ 74,676) Favourable step	€ 30,517 Bank debt 2025: € 30,517 ▼ 41% vs 2024 (€ 51,724) Favourable step	▼ 41%
Balance sheet total	€ 257,698 Balance sheet total 2022: € 257,698 First fiscal year in the series	€ 304,054 Balance sheet total 2023: € 304,054 ▲ 18% vs 2022 (€ 257,698) Unchanged	€ 219,168 Balance sheet total 2024: € 219,168 ▼ 28% vs 2023 (€ 304,054) Unchanged	€ 196,468 Balance sheet total 2025: € 196,468 ▼ 10% vs 2024 (€ 219,168) Unchanged	▼ 10%

Key figures of DUQUESNE LEGAT KINESITHERAPIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DUQUESNE LEGAT KINESITHERAPIE?

What happened at DUQUESNE LEGAT KINESITHERAPIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 29, 2026 New annual accounts for financial year 2025: profit of € 39,687 (▲ 7% vs 2024). Source: NBB ↗
Oct 4, 2018 New establishment in Estinnes. KBO
Oct 4, 2018 Start of the company according to the CBE. KBO

In short

From € 69,937 profit in 2022 to € 39,687 profit in 2025.

Paid € 78,341 in corporate taxes since 2022.

Best year ever: 2022, with € 69,937 profit.

Paid out € 223,365 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DUQUESNE LEGAT KINESITHERAPIE? We notify you, reason included.

Follow DUQUESNE LEGAT KINESITHERAPIE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Jeanne Duquesne Axel Legat

DUQUESNE LEGAT KINESITHERAPIE

Behind DUQUESNE LEGAT KINESITHERAPIE are Jeanne Duquesne and Axel Legat.

See the full network in the app

Directors

According to the 2025 annual accounts

Jeanne Duquesne

Director

Axel Legat

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Saint Roch(VBR) 17

7120 Estinnes

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0707.750.602
VAT number: BE 0707.750.602
Registered office: Rue Saint Roch(VBR) 17, 7120 Estinnes
Names & denominations: DUQUESNE LEGAT KINESITHERAPIE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 4 October 2018
Peppol: Active · Active since 24 Jan 2026

View on CBE Public ↗ Annual accounts (NBB) ↗